Lemtrada received approval from FDA

November 15, 2014 7:08 AM

3 0

Sanofi’s Lemtrada finally received a nod from the Food and Drug Administration as a potential drug to treat multiple sclerosis. The approval was a much-needed one for the company that might be facing revenue loss once its top selling diabetes drug faces competition next year.

Last year, Food and Drug Administration denied the approval of Lemtrada due its inadequate clinical trials.

Read more

To category page